Dyslipidemia and cardiovascular disease in women (Q38508952)

3 September 2017

1 reference

title

Dyslipidemia and cardiovascular disease in women (English)

1 reference

cardiovascular disease in women

3 September 2017

1 reference

0 references

1

Renata Cífková

1 reference

3 September 2017

Alena Krajčoviechová

2

1 reference

3 September 2017

1 July 2015

1 reference

Current cardiology reports

3 September 2017

1 reference

3 September 2017

17

1 reference

3 September 2017

7

1 reference

3 September 2017

609

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-015-0609-5

3 September 2017

0 references

cites work

Cardiovascular disease in Europe 2014: epidemiological update

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

The lifetime risk of stroke: estimates from the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Smoking and risk of myocardial infarction in women and men: longitudinal population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Female sex and oral contraceptive use accelerate nicotine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Distribution and correlates of high-density lipoprotein subclasses among children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Postprandial lipemia in postmenopausal women with high fasting high-density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Gender difference in postprandial lipemia : importance of visceral adipose tissue accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Oral contraceptives and myocardial infarction: results of the MICA case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Oral contraceptives and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Ischemic stroke risk with oral contraceptives: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Contraceptive hormone use and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Cholesterol and mortality. 30 years of follow-up from the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Low density lipoprotein particle size and risk of early-onset myocardial infarction in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

LDL size and risk of coronary heart disease in elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Intensive lifestyle changes for reversal of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Healthy lifestyle in the primordial prevention of cardiovascular disease among young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Meta-analysis of statin effects in women versus men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Gender disparities in evidence-based statin therapy in patients with cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Effects of combination lipid therapy in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Thyroid disease and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Statin use during pregnancy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Triglycerides and the Risk of Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-015-0609-5

Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study

21 January 2018

1 reference

12 December 2020

Adverse effect of pregnancy on high density lipoprotein (HDL) cholesterol in young adult women. The CARDIA Study. Coronary Artery Risk Development in Young Adults

1 reference

12 December 2020

Plasma lipoprotein levels as predictors of cardiovascular death in women.

1 reference

12 December 2020

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

1 reference

12 December 2020

Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study

1 reference

12 December 2020

Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension

1 reference

12 December 2020

Sex differences in the response of postprandial lipemia to a change from a low-fat low-cholesterol diet to a high-fat high-cholesterol diet

1 reference

12 December 2020

1 reference

12 December 2020

Impact of combined hormone replacement therapy on serum lipid metabolism: new aspects

1 reference

12 December 2020

The seven countries study: 2,289 deaths in 15 years

1 reference

12 December 2020

Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women.

1 reference

12 December 2020

Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study

1 reference

12 December 2020

Effects of long-term transdermal administration of estradiol on serum lipids

1 reference

12 December 2020

Serum lipids in young women before, during, and after pregnancy

1 reference

12 December 2020

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

12 December 2020

Differences in Low Density Lipoprotein Subfractions and Apolipoproteins in Premenopausal and Postmenopausal Women*

1 reference

12 December 2020

A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

1 reference

12 December 2020

Perimenopausal increase in serum cholesterol: a 10-year longitudinal study

1 reference

12 December 2020

The world health report 2002 - reducing risks, promoting healthy life

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index

1 reference

12 December 2020

10.1007/S11886-015-0609-5

Identifiers

DOI

1 reference

PubMed ID

26026998

Dimensions Publication ID

3 September 2017

0 references

1 reference

PubMed ID

26026998